Skip to content

Alto Neuroscience ANRO Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

EPS-$0.56Beat by $0.09
EPS estimate-$0.65

Next report

Aug 12, 2026 (In 2 weeks)
EPS estimate-$0.71

Financials

Q4 2024

Income statement

See full
Operating income-$17.0M-44.5%
Net income-$15.2M-35.5%
EPS (diluted)-$0.56+81.2%

Balance sheet

See full
Cash & equivalents$168.7M+104%
Total debt$15.6M+56.6%
Total equity$151.5M+311%
Total assets$177.5M+105%

Cash flow

See full
Operating cash flow-$13.0M-13.0%
CapEx$506.0K+43.8%
Free cash flow-$13.5M-13.9%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$114.08M
Enterprise value-$39.01M

Returns & leverage

See full
Debt / equity0.1×
Current ratio16.9×+1.7×

Versus estimates

Ask the moment Alto Neuroscience reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Alto Neuroscience report Q4 2024 earnings?
Alto Neuroscience (ANRO) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Alto Neuroscience's Q4 2024 revenue and EPS?
Alto Neuroscience reported eps of $-0.56 for Q4 2024.
Did Alto Neuroscience beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.65 by $0.09.
Where can I find Alto Neuroscience's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001999480-25-000025) directly on SEC EDGAR. The filing index links above go to sec.gov.